Nitric oxide in HIV-1 perinatally infected children treated with highly active antiretroviral therapy

Lancet Infect Dis. 2003 Mar;3(3):128-9; author reply 129-30. doi: 10.1016/s1473-3099(03)00541-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Child
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism*
  • HIV Infections / transmission
  • HIV-1 / physiology*
  • Humans
  • Infectious Disease Transmission, Vertical
  • Nitric Oxide / metabolism*

Substances

  • Anti-HIV Agents
  • Nitric Oxide